Envista Holdings Corporation (NVST)
Here's What Key Metrics Tell Us About Envista (NVST) Q1 Earnings
The headline numbers for Envista (NVST) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Envista (NVST) Surpasses Q1 Earnings and Revenue Estimates
Envista (NVST) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.24 per share a year ago.
Here's Why Envista (NVST) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why You Should Add NVST Stock to Your Portfolio Right Now
Envista Holdings Corporation's NVST strategic priorities position it for robust growth in the upcoming quarters. The company is positioned to benefit from favorable long-term dental industry trends.
Envista Stock Up 42.5% in a Year: What's Driving It?
Envista NVST shares have climbed 42.5% over the past year, showcasing impressive momentum. The stock has outpaced the industry's 22.5% decline and the S&P 500 composite's 16.6% gain.
NVST or SYK: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now?
Best Value Stocks to Buy for March 16th
OPRX, NVST and STRT made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 16, 2026.
All You Need to Know About Envista (NVST) Rating Upgrade to Strong Buy
Envista (NVST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Here's Why Envista (NVST) Is a Great 'Buy the Bottom' Stock Now
Envista (NVST) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
NVST vs. ESLOY: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two stocks presents investors with the better value opportunity right now?
Here's Why Envista (NVST) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Envista (NVST) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
